Kolyadina, I V <br/><br/>
[Role of clustered HER2/neu amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer].  [electronic resource] 

 -  Arkhiv patologii  2019 
 - 56-62 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0004-1955 
<br/><br/><label>Standard No.: </label>10.17116/patol20198106156  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Biomarkers, Tumor<br/>Breast Neoplasms--therapy<br/>Female<br/>Gene Amplification<br/>Humans<br/>Mastectomy<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Staging<br/>Receptor, ErbB-2<br/>Trastuzumab